Login / Signup

Allergy and Immunotherapy During the Pandemic.

Elizabeth Mahoney Davis
Published in: Current otorhinolaryngology reports (2022)
Resuming outpatient allergy services in the setting of the COVID-19 pandemic poses many challenges to the practitioner. Allergy specialists are now faced with developing prudent and evidence-based strategies for safely resuming allergen immunotherapy, while also maintaining a safe environment for staff and patients.
Keyphrases
  • end stage renal disease
  • atopic dermatitis
  • ejection fraction
  • healthcare
  • newly diagnosed
  • chronic kidney disease
  • sars cov
  • coronavirus disease
  • primary care
  • mental health
  • infectious diseases
  • affordable care act